Discovery of (+)-N-(3-Aminopropyl)-N-[1-(5-benzyl-3-metlyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-metlylpropyl]-4-methylbenzamide (AZD4877), a Kinesin Spindle Protein Inhibitor and Potential Anticancer Agent

被引：40

作者：

Theoclitou, Maria-Elena ^{[1
]}

Aquila, Brian ^{[2
]}

Block, Michael H. ^{[2
]}

Brassil, Patrick J. ^{[2
]}

Castriotta, Lillian ^{[2
]}

Code, Erin ^{[2
]}

Collins, Michael P. ^{[2
]}

Davies, Audrey M. ^{[2
]}

Deegan, Tracy ^{[2
]}

Ezhuthachan, Jayachandran ^{[2
,3
]}

Filla, Sandra ^{[2
,3
]}

Freed, Ellen ^{[2
,3
]}

Hu, Haiqing ^{[2
]}

Huszar, Dennis ^{[2
]}

Jayaraman, Muthusamy

Lawson, Deborah ^{[2
]}

Lewis, Paula M. ^{[2
]}

Nadella, Murali V. P. ^{[2
]}

Oza, Vibha ^{[2
]}

Padmanilayam, Maniyan ^{[4
]}

Pontz, Timothy ^{[2
]}

Ronco, Lucienne ^{[2
,3
]}

Russell, Daniel ^{[2
]}

Whitston, David ^{[2
]}

Zheng, Xiaolan ^{[2
]}

机构：

[1] AstraZeneca, Canc & Infect Res Area, Macclesfield SK10 4TG, Cheshire, England

[2] AstraZeneca R&D Boston, Canc & Infect Res Area, Waltham, MA 02451 USA

[3] AstraZeneca Boston, Boston, MA USA

[4] Organix Inc, Woburn, MA 01801 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2011年 / 54卷 / 19期

关键词：

MITOTIC MOTOR PROTEIN; ANTIMITOTIC DRUG; EG5; MICROTUBULES; MECHANISMS; RESISTANCE; CANCER; TAXOL; KSP; BIPOLARITY;

D O I：

10.1021/jm200629m

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Structure activity relationship analysis identified (+)-N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), from a series of novel kinesin spindle protein (KSP) inhibitors, as exhibiting both excellent biochemical potency and pharmaceutical properties suitable for clinical development. The selected compound arrested cells in mitosis leading to the formation of the monopolar spindle phenotype characteristic of KSP inhibition and induction of cellular death. A favorable pharmacokinetic profile and notable in vivo efficacy supported the selection of this compound as a clinical candidate for the treatment of cancer.

引用

页码：6734 / 6750

页数：17

共 50 条

[21] Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 Inhibitor
Coluccia, Antonio
Bufano, Marianna
La Regina, Giuseppe
Puxeddu, Michela
Toto, Angelo
Paone, Alessio
Bouzidi, Amani
Musto, Giorgia
Badolati, Nadia
Orlando, Viviana
Biagioni, Stefano
Masci, Domiziana
Cantatore, Chiara
Cirilli, Roberto
Cutruzzola, Francesca
Gianni, Stefano
Stornaiuolo, Mariano
Silvestri, Romano
CANCERS, 2022, 14 (05)
[22] Discovery of N-[4-[6-tert-Butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a Potent Inhibitor of the Hepatitis C Virus NS5B Polymerase
Talamas, Francisco X.
Abbot, Sarah C.
Anand, Shalini
Brameld, Ken A.
Carter, David S.
Chen, Jun
Davis, Dana
de Vicente, Javier
Fung, Amy D.
Gong, Leyi
Harris, Seth F.
Inbar, Petra
Labadie, Sharada S.
Lee, Eun K.
Lemoine, Remy
Le Pogam, Sophie
Leveque, Vincent
Li, Jim
McIntosh, Joel
Najera, Isabel
Park, Jaehyeon
Railkar, Aruna
Rajyaguru, Sonal
Sangi, Michael
Schoenfeld, Ryan C.
Staben, Leanna R.
Tan, Yunchou
Taygerly, Joshua P.
Villasenor, Armando G.
Weller, Paul E.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 1914 - 1931
[23] Structure-Based Drug Discovery of N-((R)-3-(7-Methyl-1H-indazol-5-yl)-1-oxo-1-(((S)-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2′-oxo-1′,2′-dihydrospiro[piperidine-4,4′-pyrido[2,3-d][1,3]oxazine]-1-carboxamide (HTL22562): A Calcitonin Gene-Related Peptide Receptor Antagonist for Acute Treatment of Migraine
Bucknell, Sarah J.
Ator, Mark A.
Brown, Alastair J. H.
Brown, Jason
Cansfield, Andrew D.
Cansfield, Julie E.
Christopher, John A.
Congreve, Miles
Cseke, Gabriella
Deflorian, Francesca
Jones, Christopher R.
Mason, Jonathan S.
O'Brien, M. Alistair
Ott, Gregory R.
Pickworth, Mark
Southall, Stacey M.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (14) : 7906 - 7920
[24] Discovery of 2-(2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino [2′,3′:3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor
Muthukaman, Nagarajan
Deshmukh, Sanjay
Sarode, Neelam
Tondlekar, Shital
Tambe, Macchindra
Pisal, Dnyandeo
Shaikh, Mahamadhanif
Kattige, Vidya G.
Honnegowda, Srinivasa
Karande, Vikas
Kulkarni, Abhay
Jadhav, Satyawan B.
Mahat, Mahamad Yunnus A.
Gudi, Girish S.
Khairatkar-Joshi, Neelima
Gharat, Laxmikant A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (24) : 5977 - 5984
[25] Discovery of a Novel Glucagon Receptor Antagonist N-[(4-{(1S)-1-[3-(3, 5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the Treatment of Type II Diabetes
Xiong, Yusheng
Guo, Jian
Candelore, Mari R.
Liang, Rui
Miller, Corey
Dallas-Yang, Qing
Jiang, Guoqiang
McCann, Peggy E.
Qureshi, Sajjad A.
Tong, Xinchun
Xu, Shiyao Sherrie
Shang, Jackie
Vincent, Stella H.
Tota, Laurie M.
Wright, Michael J.
Yang, Xiaodong
Zhang, Bei B.
Tata, James R.
Parmee, Emma R.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (13) : 6137 - 6148
[26] Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis
Ruminski, Peter G.
Massa, Mark
Strohbach, Joseph
Hanau, Cathleen E.
Schmidt, Michelle
Scholten, Jeffrey A.
Fletcher, Theresa R.
Hamper, Bruce C.
Carroll, Jeffery N.
Shieh, Huey S.
Caspers, Nicole
Collins, Brandon
Grapperhaus, Margaret
Palmquist, Katherine E.
Collins, Joe
Baldus, John E.
Hitchcock, Jeffrey
Kleine, H. Peter
Rogers, Michael D.
McDonald, Joseph
Munie, Grace E.
Messing, Dean M.
Portolan, Silvia
Whiteley, Laurence O.
Sunyer, Teresa
Schnute, Mark E.
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (01) : 313 - 327
[27] SYNTHESES OF A REGIOISOMER OF N-[4-[2-(2-AMINO-4(3H)-OXO-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)ETHYL]BENZOYL)-L-GLUTAMIC ACID (LY231514), AN ACTIVE THYMIDYLATE SYNTHASE INHIBITOR AND ANTITUMOR AGENT
TAYLOR, EC
YOUNG, WB
CHAUDHARI, R
PATEL, HH
HETEROCYCLES, 1993, 36 (08) : 1897 - 1908
[28] The Discovery of N-(1-Methy1-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6-((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration
Adams, Christopher M.
Anderson, Karen
Artman, Gerald, III
Bizec, Jean-Claude
Cepeda, Rosemarie
Elliott, Jason
Fassbender, Elizabeth
Ghosh, Malay
Hanks, Shawn
Hardegger, Leo A.
Hosagrahara, Vinayak P.
Jaffee, Bruce
Jendza, Keith
Ji, Nan
Johnson, Leland
Lee, Wendy
Liu, Donglei
Liu, Fang
Long, Debby
Ma, Fupeng
Mainolfi, Nello
Meredith, Erik L.
Miranda, Karl
Peng, Yao
Poor, Stephen
Powers, James
Qu, Yubin
Rao, Chang
Shen, Siyuan
Sivak, Jeremy M.
Solovay, Catherine
Tarsa, Peter
Woolfenden, Amber
Zhang, Chun
Zhang, Yiqin
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (04) : 1622 - 1635
[29] Discovery of 1-[3-(1-Methyl-1H-pyrazol-4-y1)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron Dual Kinase Inhibitor with Preferential Affinity for the Activated State of c-Met
Northrup, Alan B.
Katcher, Matthew H.
Altman, Michael D.
Chenard, Melissa
Daniels, Matthew H.
Deshmukh, Sujal V.
Falcone, Danielle
Guerin, David J.
Hatch, Harold
Li, Chaomin
Lu, Wei
Lutterbach, Bart
Allison, Timothy J.
Patel, Sangita B.
Reily, John F.
Reutershan, Michael
Rickert, Keith W.
Rosenstein, Craig
Soisson, Stephen M.
Szewczak, Alexander A.
Walker, Deborah
Wilson, Kevin
Young, Jonathan R.
Pan, Bo-Sheng
Dinsmore, Christopher J.
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (06) : 2294 - 2310
[30] Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model
Fales, Kevin R.
Njoroge, F. George
Brooks, Harold B.
Thibodeaux, Stefan
Torrado, Alicia
Si, Chong
Toth, James L.
Mc Cowan, Jefferson R.
Roth, Kenneth D.
Thrasher, Kenneth J.
Frimpong, Kwame
Lee, Matthew R.
Dally, Robert D.
Shepherd, Timothy A.
Durham, Timothy B.
Margolis, Brandon J.
Wu, Zhipei
Wang, Yong
Atwell, Shane
Wang, Jing
Hui, Yu-Hua
Meier, Timothy I.
Konicek, Susan A.
Geeganage, Sandaruwan
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (23) : 9599 - 9616

← 1 2 3 4 5 →